XNCR (Xencor) Beginning Cash Position: $14.4 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XNCR Xencor Inc XNCR
60 GF Score
Price $21.58
GF Value $12.72
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Xencor Beginning Cash Position?

Xencor XNCR +4.10% 60 Beginning Cash Position is $14.4 Mil as of Jun. 2026. GuruFocus rates XNCR with a GF Score™ of 60/100 and a GF Value™ of $12.72 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Xencor's Beginning Cash Position for the quarter that ended in Jun. 2026 was $14.4 Mil.

Xencor's quarterly Beginning Cash Position increased from Dec. 2025 ($28.6 Mil) to Mar. 2026 ($54.4 Mil) but then declined from Mar. 2026 ($54.4 Mil) to Jun. 2026 ($14.4 Mil).

Xencor's annual Beginning Cash Position increased from Dec. 2023 ($53.9 Mil) to Dec. 2024 ($54.2 Mil) but then declined from Dec. 2024 ($54.2 Mil) to Dec. 2025 ($41.3 Mil).

Xencor Beginning Cash Position Related Terms

Xencor Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Xencor's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xencor Beginning Cash Position Chart

Xencor Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 163.54 143.48 53.94 54.17 41.26

Xencor Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.96 44.73 28.58 54.36 14.36
XNCR
60GF Score
Xencor Inc XNCR
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xencor Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $14.4 Mil mean?
Xencor (XNCR) has a Beginning Cash Position of $14.4 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Xencor and its competitors.
Is Xencor's Beginning Cash Position too high?
Xencor's current Beginning Cash Position is $14.4 Mil. Overall, Xencor has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Xencor's Beginning Cash Position compare to VIR and AVBP?
Xencor's Beginning Cash Position of $14.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Xencor and its competitors. Xencor's current Beginning Cash Position is $14.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xencor stock overvalued right now?
Based on GuruFocus' analysis, Xencor (XNCR) is currently considered Significantly Overvalued. The stock's GF Value™ is $12.72, compared to a current price of $21.58 — trading 69.7% above its estimated fair value. The current Beginning Cash Position is $14.4 Mil. Xencor's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Xencor (XNCR), the current Beginning Cash Position is $14.4 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xencor (XNCR) Overvalued in 2026?

Based on GuruFocus' analysis, Xencor stock appears to be overvalued. The current stock price of $21.58 is trading 69.7% above its estimated GF Value™ of $12.72. GuruFocus considers Xencor to be Significantly Overvalued.

Key valuation signals for XNCR:

  • Beginning Cash Position: $14.4 Mil
  • GF Value™: $12.72 vs. price of $21.58 (69.7% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the XNCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xencor Business Description

Other Exchanges XE9:Germany
Address 465 North Halstead Street, Suite 200, Pasadena, CA, USA, 91107
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
60GF Score

Get the complete analysis for XNCR

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.58
Price
$12.72
GF Value